Cardiff Oncology (CRDF) Competitor Comparison
We are evaluating the key criteria listed to compare Cardiff Oncology (CRDF) against its competitors in the Biotechnology industry.
Market Capitalization
272 / 368Gross Profits
177 / 278Total Revenue
252 / 300EBITDA
131 / 337Free Cashflow
134 / 352Quick Ratio
91 / 357Earnings per Share
124 / 359Dividend yield
0 / 6Total Cash
231 / 358Performance 3 years
133 / 368Performance 5 years
32 / 368Performance 10 years
321 / 368Linearity 3 years
110 / 368Linearity 5 years
221 / 368Linearity 10 years
248 / 367Total Rank
300 / 368Dividend Rank
76 / 368Valuation Rank
332 / 368Piotroski Rank
262 / 368Muliplier Rank
303 / 368Market Capitalization - CRDF ranking 272 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.